Amoxicillin/clavulanic acid: if possible, avoid fasting state [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2018-06-03 17:47 (879 d 02:13 ago) – Posting: # 18849
Views: 2,308

Hi Amira!

» […] if the BE study for amoxicillin/clavulanic acid is done under fast or fed conditions with references please??

Please do you homework first (see also this post #3).

The FDA requires two studies (fasting & fed). IMHO, that’s not a good approach because you might face a lot of nasty GI-related AEs in fasting state.

IMHO, the EMA’s GL is better (Section 4.1.1):

For products where the SmPC recommends intake of the reference medicinal product only in fed state, the bioequivalence study should generally be conducted under fed conditions.

The SmPC:

Augmentin should be administered with a meal to minimise potential gastrointestinal intolerance.

In our studies we didn’t serve a high-fat high-calory meal but a light breakfast as a compromise (since fasting is considered more discriminatory).

Dif-tor heh smusma 🖖
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

 Admin contact
21,179 posts in 4,414 threads, 1,477 registered users;
online 3 (0 registered, 3 guests [including 1 identified bots]).
Forum time: Thursday 20:01 UTC (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz